Analysts
Bryan, Garnier & Co: Alex Cogut
Rx Securities: Joseph Hedden
Carnegie: Arvid Necander & Erik Hultgård
Pareto Securities: Dan Akschuti
ABG Sundal Collier: Gonzalo Artiach
Redeye: Fredrik Thor
Erik Penser Bank: Ludvig Svensson
Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Bryan, Garnier & Co: Alex Cogut
Rx Securities: Joseph Hedden
Carnegie: Arvid Necander & Erik Hultgård
Pareto Securities: Dan Akschuti
ABG Sundal Collier: Gonzalo Artiach
Redeye: Fredrik Thor
Erik Penser Bank: Ludvig Svensson
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com